Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

Clinical trial NCT07636486 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07636486
Sponsor: Nanfang Hospital, Southern Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Luspatercept Epoetin Poor Erythroid Engraftment Hematological Malignancies

Start date: 2026-06-15
Primary completion: 2028-06-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.